Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,808,443Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Accord BioPharma

02 8Accord healthcare

03 10Amgen Inc

04 1Aprogen

05 16Arrotex Pharmaceuticals

06 6AstraZeneca

07 2BIOSIMILAR COLLABORATIONS IRELAND LIMITED

08 4Biosimilar Collaborations Ireland Limited

09 39Celltrion

10 2CinnaGen

11 1Cipla Medpro South Africa

12 1Clinigen Group

13 1CuraTeQ Biologics

14 3Daiichi Sankyo

15 29F. Hoffmann-La Roche

16 3Genentech

17 1Imperial Market Access Healthcare SA (Pty) Ltd

18 2Iqone Healthcare Switzerland Sa

19 2Medius Ag

20 32Pfizer Consumer Healthcare

21 9Pfizer Inc

22 2Prestige BioPharma Pte Ltd

23 8Roche Diagnostics GmbH

24 8Samsung Bioepis

25 17Sandoz B2B

26 1Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-STRF

Brand Name : HERCESSI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 761346

Regulatory Info :

Registration Country : USA

blank

02

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-ANNS

Brand Name : KANJINTI

Dosage Form : VIAL; MULTIDOSE

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 761073

Regulatory Info :

Registration Country : USA

blank

03

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-ANNS

Brand Name : KANJINTI

Dosage Form : VIAL;SINGLE-DOSE

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 761073

Regulatory Info :

Registration Country : USA

blank

04

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Trastuzumab

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

05

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-PKRB

Brand Name : HERZUMA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 761091

Regulatory Info :

Registration Country : USA

blank

06

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Trastuzumab

Brand Name : AryoTrust

Dosage Form : Injectable

Dosage Strength : 150MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

07

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Trastuzumab

Brand Name : AryoTrust

Dosage Form : Injectable

Dosage Strength : 440MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

08

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Trastuzumab

Brand Name : Herceptin

Dosage Form : Trastuzumab 150Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial groun EV 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Trastuzumab

Brand Name : Herceptin

Dosage Form : Trastuzumab 600Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial SC 600 mg/5 ml 6 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Pertuzumab; Trastuzumab

Brand Name : Phesgo

Dosage Form : Injectable Solution

Dosage Strength : 1200mg;600mg

Packaging :

Approval Date : 21/12/2020

Application Number : 20200111000010

Regulatory Info : Approved

Registration Country : Sweden

blank

11

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Pertuzumabum; Trastuzumabum

Brand Name : Phesgo mg

Dosage Form : Solution For Injection

Dosage Strength : 600mg/10ml;600mg/10ml

Packaging :

Approval Date : 08/04/2021

Application Number : 67828

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Pertuzumabum; Trastuzumabum

Brand Name : Phesgo mg

Dosage Form : Solution For Injection

Dosage Strength : 1200mg/15ml;600mg/15ml

Packaging :

Approval Date : 08/04/2021

Application Number : 67828

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

Pertuzumab; Trastuzumab

Brand Name : Phesgo

Dosage Form : Injectable Solution

Dosage Strength : 600mg/ml;600mg/ml

Packaging :

Approval Date : 21/12/2020

Application Number : 20200111000027

Regulatory Info : Approved

Registration Country : Sweden

blank

14

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB

Brand Name : HERCEPTIN

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 21MG/ML

Packaging :

Approval Date :

Application Number : 103792

Regulatory Info :

Registration Country : USA

blank

15

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 1,200MG;600MG;30,000UNITS

Packaging :

Approval Date :

Application Number : 761170

Regulatory Info :

Registration Country : USA

blank

16

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 600MG;600MG;20,000UNITS

Packaging :

Approval Date :

Application Number : 761170

Regulatory Info :

Registration Country : USA

blank

17

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-QYYP

Brand Name : TRAZIMERA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 761081

Regulatory Info :

Registration Country : USA

blank

18

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-DTTB

Brand Name : ONTRUZANT

Dosage Form : POWDER;IV (INFUSION)

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 761100

Regulatory Info :

Registration Country : USA

blank

19

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-DTTB

Brand Name : ONTRUZANT

Dosage Form : POWDER;IV (INFUSION)

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 761100

Regulatory Info :

Registration Country : USA

blank

20

CTAD25
Not Confirmed
arrow
arrow
CTAD25
Not Confirmed

TRASTUZUMAB-DKST

Brand Name : OGIVRI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 420MG/VIAL

Packaging :

Approval Date :

Application Number : 761074

Regulatory Info :

Registration Country : USA

blank